Fluconazole.
Indian J Pediatr
;
1996 Nov-Dec; 63(6): 775-80
Artigo
em Inglês
| IMSEAR
| ID: sea-81809
ABSTRACT
Incidence of systemic candidiasis is increasing with improvement in the survival of high risk neonates who undergo multiple interventions. Therapies available to treat systemic fungal infection are few and have several drawbacks. Fluconazole, a new triazole derivative may be a useful anti-fungal agent in view of its excellent oral absorption, easy administration, low plasma protein affinity, long half-life, high concentrations in urine and CSF, minimal adverse reactions, wide spectrum of anti-fungal activity and high specificity for fungal cytochrome P450 system. Its utility in neonates and children with candidiasis has already been documented by few case reports and studies.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Humanos
/
Candidíase
/
Recém-Nascido
/
Fluconazol
/
Criança
/
Pré-Escolar
/
Resultado do Tratamento
/
Lactente
/
Antifúngicos
Idioma:
Inglês
Revista:
Indian J Pediatr
Ano de publicação:
1996
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS